Distribution of 14 High-Risk HPV Types and p16/Ki67 Dual-Stain Status in Post-Colposcopy Histology Results: Negative, Low- and High-Grade Cervical Squamous Intraepithelial Lesions

被引:0
|
作者
Mazurec, Karolina [1 ]
Trzeszcz, Martyna [1 ,2 ]
Mazurec, Maciej [1 ]
Kobierzycki, Christopher [3 ]
Jach, Robert [4 ]
Halon, Agnieszka [5 ]
机构
[1] Corfamed Womans Hlth Ctr, Kluczborska 37, PL-50322 Wroclaw, Poland
[2] Univ Hosp Wroclaw, Div Pathol & Clin Cytol, Borowska 213, PL-50556 Wroclaw, Poland
[3] Wroclaw Med Univ, Dept Human Morphol & Embryol, Div Histol & Embryol, Chalubinskiego 6a, PL-50368 Wroclaw, Poland
[4] Jagiellonian Univ Med Coll, Div Gynecol Endocrinol, Kopern 23, PL-31501 Krakow, Poland
[5] Wroclaw Med Univ, Dept Clin & Expt Pathol, Div Clin Pathol, Borowska 213, PL-50556 Wroclaw, Poland
关键词
cervical cancer screening; human papillomavirus; high-risk HPV; HPV genotyping; cervical intraepithelial neoplasia; p16/Ki67 dual staining; risk stratification; HUMAN-PAPILLOMAVIRUS TYPES; CANCER; WOMEN; GUIDELINES; MANAGEMENT;
D O I
10.3390/cancers16193401
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Determining the distribution of high-risk human papillomavirus (HR-HPV) types in histologic low-(LSIL) and high-grade (HSIL/CIN2+) squamous intraepithelial lesions through a diagnostic process in a cervical cancer prevention provides one of the key etiological factors behind further progression and persistence. Incorporating novel high-grade cervical lesion biomarkers such as p16/Ki67 dual staining (DS) alongside HPV typing has become important in detecting cervical precancers.Methods: Among 28,525 screening tests and 602 histology results, 559 cases with HR-HPV and histology results obtained from colposcopic biopsy were retrospectively analyzed, together with DS status. The chi 2 test with Bonferroni correction evaluated the differences in HR-HPV type prevalence and DS positivity across three histologic study groups. Results: A statistically significant difference in the prevalence of HPV 16 was observed between negative and HSIL/CIN2+ (p = 0.00027) groups, as well as between the LSIL/CIN1 and HSIL/CIN2+ groups (p = 0.00041). However, no significant difference was found between the negative and LSIL/CIN1 groups. Similarly, the DS positivity difference was significant between the negative and HSIL/CIN2+ (p < 0.0001) and between the LSIL/CIN1 and HSIL/CIN2+ groups (p < 0.0001), but there was no significant difference between the negative and LSIL/CIN1 groups. Conclusions: The study highlights the heterogeneous nature of HPV-related cervical pathologies, and the distinct risks associated with different cervical lesion grades, emphasizing the importance of HR-HPV type distribution and DS status.
引用
收藏
页数:12
相关论文
共 33 条
  • [1] p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions
    Zhang, Ruiyi
    Ge, Xuefei
    You, Ke
    Guo, Yanli
    Guo, Hongyan
    Wang, Yanjie
    Geng, Li
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2018, 44 (11) : 2077 - 2084
  • [2] Triaging Atypical Squamous Cells-Cannot Exclude High-Grade Squamous Intraepithelial Lesion With p16/Ki67 Dual Stain
    Sekoranja, Daja
    Fokter, Alenka Repse
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2017, 21 (02) : 108 - 111
  • [3] Association of p16 and Ki-67 with Risk of Recurrence in Previously Treated Cervical High-Grade Squamous Intraepithelial Lesions
    Arredondo-Galvez, Carlos German
    Acuna-Gonzalez, Denise
    Cantu-de-Leon, David
    Chanona-Vilchis, Jose Gregorio
    Aviles-Salas, Alejandro
    Gonzalez-Enciso, Aaron
    Bandala-Jaques, Antonio
    Barquet-Munoz, Salim Abraham
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2021, 86 (03) : 293 - 298
  • [4] Comparison of HPV 16/18 Genotyping and p16/Ki67 Dual Staining for Detection of High-Grade Cervical Lesion in Patients with Low-Grade Cervical Smears
    Chadha, Saloni
    Gandhi, Gauri
    Hedau, Suresh T. T.
    Gupta, Ruchika
    JOURNAL OF OBSTETRICS AND GYNECOLOGY OF INDIA, 2023, 73 (03) : 248 - 253
  • [5] Histomorphologic assessment and distribution of high-risk human papillomavirus (HPV) types in cervical high-grade squamous intraepithelial lesions with unusual histomorphologic features
    Gutnik, Helena
    Kastelic, Primoz
    Ostrbenk Valencak, Anja
    Poljak, Mario
    Strojan Flezar, Margareta
    VIRCHOWS ARCHIV, 2020, 476 (02) : 251 - 260
  • [6] Efficacy of p16 and Ki-67 immunostaining in the detection of squamous intraepithelial lesions in a high-risk HPV group
    Lim, Sharon
    Lee, Mi Ja
    Cho, Inju
    Hong, Ran
    Lim, Sung Caul
    ONCOLOGY LETTERS, 2016, 11 (02) : 1447 - 1452
  • [7] Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study
    El-Zein, Mariam
    Gotlieb, Walter
    Gilbert, Lucy
    Hemmings, Robert
    Behr, Marcel A.
    Franco, Eduardo L.
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (02) : 492 - 501
  • [8] HPV16 genotype, p16/Ki-67 dual staining and koilocytic morphology as potential predictors of the clinical outcome for cervical low-grade squamous intraepithelial lesions
    Vrdoljak-Mozetic, D.
    Krasevic, M.
    Ostojic, D. Versa
    Stemberger-Papic, S.
    Rubesa-Mihaljevic, R.
    Bubonja-Sonje, M.
    CYTOPATHOLOGY, 2015, 26 (01) : 10 - 18
  • [9] Comparison of HPV 16/18 Genotyping and p16/Ki67 Dual Staining for Detection of High-Grade Cervical Lesion in Patients with Low-Grade Cervical Smears
    Saloni Chadha
    Gauri Gandhi
    Suresh T. Hedau
    Ruchika Gupta
    The Journal of Obstetrics and Gynecology of India, 2023, 73 : 248 - 253
  • [10] Sensitivity and specificity values of high-risk HPV DNA, p16/ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL)
    Frega, A.
    Pavone, M.
    Sesti, F.
    Leone, C.
    Bianchi, P.
    Cozza, G.
    Colombrino, C.
    Lukic, A.
    Marziani, R.
    De Sanctis, L.
    Carpini, G. Delli
    Caserta, D.
    Ciavattini, A.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (24) : 10672 - 10677